| RS1554900599 |
PTEN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554900606 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1554900615 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS1554900620 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1554900622 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1554900626 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1554900629 |
PTEN
|
Health Risk |
Pathogenic |
— |
| RS1554900635 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1554900638 |
PTEN
|
Health Risk |
Pathogenic |
— |
| RS1554900673 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554900675 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, Neoplasm |
| RS1554901463 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554901472 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554901523 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Neuronal ceroid lipofuscinosis 2 |
| RS1554901576 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS1554901580 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554901596 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 2 diabetes mellitus, Maturity-onset diabetes of the young type 13 |
| RS1554901674 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1554901718 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Type 2 diabetes mellitus |
| RS1554901731 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554901747 |
KCNJ11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypoglycemia, Diabetes mellitus |
| RS1554901775 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Permanent neonatal diabetes mellitus |
| RS1554901784 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS1554901796 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554901822 |
KCNJ11
|
Health Risk |
Likely pathogenic |
DEND syndrome, Maturity-onset diabetes of the young |
| RS1554901895 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554901898 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554902020 |
TPP1
|
Health Risk |
Pathogenic |
— |
| RS1554902043 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554902052 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 2 |
| RS1554902085 |
TPP1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS1554902216 |
TPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS1554902217 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS1554902528 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1554902760 |
CWF19L1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 17, Autosomal recessive spinocerebellar ataxia 17 |
| RS1554902811 |
RECQL4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554902885 |
EBF3
|
Health Risk |
Likely pathogenic |
— |
| RS1554903709 |
RECQL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Baller-Gerold syndrome, Rothmund-Thomson syndrome type 2 |
| RS1554903728 |
HPS6
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS1554903804 |
KCNQ1
|
Health Risk |
Pathogenic |
Jervell and Lange-Nielsen syndrome 1, Jervell and Lange-Nielsen syndrome 1 |
| RS1554903842 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554903979 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554904006 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1554904102 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554904107 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554904136 |
ABCC8
|
Health Risk |
Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1554904159 |
BRSK2
|
Health Risk |
Pathogenic |
— |
| RS1554904186 |
CWF19L1
|
Health Risk |
Pathogenic |
— |
| RS1554904330 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS1554904554 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554904565 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554904685 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1554904702 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Inborn genetic diseases |
| RS1554904772 |
BRSK2
|
Health Risk |
Likely pathogenic |
— |
| RS1554904773 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1554904904 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554904936 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Transitory neonatal diabetes mellitus |
| RS1554905068 |
LGI1
|
Health Risk |
Likely pathogenic |
— |
| RS1554905145 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Transitory neonatal diabetes mellitus |
| RS1554905662 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554906003 |
BRSK2
|
Health Risk |
Pathogenic |
— |
| RS1554906133 |
GLUD1
|
Health Risk |
Pathogenic |
— |
| RS1554906449 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554906579 |
BLNK
|
Health Risk |
Pathogenic |
Agammaglobulinemia 4, autosomal recessive |
| RS1554906786 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1554906790 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554907337 |
FGFR2
|
Health Risk |
Likely pathogenic |
Levy-Hollister syndrome, Levy-Hollister syndrome |
| RS1554907364 |
FGFR2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554907767 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS1554907787 |
LGI1
|
Health Risk |
Pathogenic |
Autosomal dominant epilepsy with auditory features, Autosomal dominant epilepsy with auditory features |
| RS1554907835 |
LGI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant epilepsy with auditory features, Inborn genetic diseases |
| RS1554908290 |
EHMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1554908367 |
EHMT1
|
Health Risk |
Likely pathogenic |
— |
| RS1554908411 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1554909277 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Permanent neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS1554910610 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554911369 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554911430 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554911481 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554911731 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554911807 |
DNA2
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA deletion syndrome with progressive myopathy, Mitochondrial DNA deletion syndrome with progressive myopathy |
| RS1554913069 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1554914180 |
FGFR2
|
Health Risk |
Likely pathogenic |
— |
| RS1554917411 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554917471 |
FGFR2
|
Health Risk |
Likely pathogenic |
Levy-Hollister syndrome, Levy-Hollister syndrome |
| RS1554917561 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1554917831 |
HBB
|
Health Risk |
Likely pathogenic |
— |
| RS1554917888 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS1554917935 |
HBB
|
Health Risk |
Pathogenic |
— |
| RS1554917947 |
HBB
|
Health Risk |
Likely pathogenic |
Beta-thalassemia HBB/LCRB, Beta-thalassemia HBB/LCRB |
| RS1554917970 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1554918013 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554918032 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS1554918165 |
HBB
|
Health Risk |
Likely pathogenic |
beta Thalassemia, Beta-thalassemia HBB/LCRB |
| RS1554918177 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554918214 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS1554919471 |
KCNQ1
|
Health Risk |
Pathogenic |
Jervell and Lange-Nielsen syndrome 1, Jervell and Lange-Nielsen syndrome 1 |
| RS1554920552 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal insulin-dependent diabetes mellitus, Neonatal insulin-dependent diabetes mellitus |
| RS1554920580 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1554920833 |
KCNQ1
|
Health Risk |
Pathogenic |
Jervell and Lange-Nielsen syndrome 1, Jervell and Lange-Nielsen syndrome 1 |